EpimAb Biotherapeutics commences dosing in phase I/II trials of EMB-06 and EMB-02 July 7, 2021 No Comments
FDA clears initiation of phase II trials of YH-001 and YH-003 in advanced cancers July 7, 2021 No Comments
NextCure's NC-762 enters phase I/II trial in advanced or metastatic solid tumors July 7, 2021 No Comments
Phase I/II trial explores Gadeta's gamma delta TCR cell therapy GDT-002 for multiple myeloma July 6, 2021 No Comments
BCMA CAR-T cells engineered with membrane-bound IL-15 show increased in vivo activity July 6, 2021 No Comments
Mersana starts phase I/II umbrella study of XMT-1536 in high-grade serous ovarian cancer July 6, 2021 No Comments
RSS